Pharmaceutical Degradation: Types and Factors

 
PHARMACEUTICAL
 
DEGRADATION
 
P
R
E
S
E
N
T
E
D
 
B
Y
:
Rama Shukla
Deptt. of Pharmaceutics,
LNCP,Bhopal
 
D
E
GRA
D
A
TI
O
N
 
The condition 
or 
process 
of
degrading 
or 
being
degraded.Decline 
to 
a 
lower
quality,condition  
or
 
level.
 
PHARMACEUTICAL
 
DEGRADATION
 
The incapacity or incapability of 
a
particular 
formulation 
in a 
specific
container 
to 
remain 
within a
particular 
chemical, 
microbiological,
therapeutical, 
physical 
& 
toxicological
specification
.
 
ASPIRIN
 
Decompose 
into 
acetic 
acid and 
salicylic
 
acid
giving the 
acetic 
acid 
odour 
by 
the 
break 
down.
The 
breakdown 
is a 
chemical reaction 
involving
the 
collisions 
of 
the 
molecules.This breakdown 
is
affected 
by various 
factors 
such 
as 
presence of
oxygen, 
acidity, 
alkalinity, 
moisture 
and 
light. This
breakdown 
is 
what 
we 
are 
calling
 
degradation
.
 
TYPES 
OF PHARMACEUTICAL
DEGRADATION
 
Pharmaceutical 
degradation 
is 
of 
following
type.
It 
can
 
be
 
divided 
into 
three 
major
 
types:
1.
Physical
 
degradation
2.
Chemical
 
degradation
3.
Microbiological
 
degradation
 
PHYSICAL
 
DEGRADATION
 
It is the 
degradation 
which 
results 
into
the 
change of 
physical 
nature 
of
 
drug.
The 
formulation 
is 
totally
 
changed
 
by
way 
of appearance, 
organoleptic
properties, hardness, 
brittleness, 
particle
size.
 
Factors 
effecting physical 
degradation 
are
as
 
under:
1.
Loss of volatile
 
components
2.
Loss of
 
H2O
3.
Absorption of
 
H2O
4.
Crystal
 
growth
5.
Polymorphic changes
6.
Colour
 
changes
 
1)
 
Loss 
Of 
Volatile
 
Components:
 
Many 
drugs 
and 
excipients 
may 
be 
lost 
from
pharmaceutical 
products at 
ambient  
temperature
through
 
vaporization.
These  
Volatile 
components such
 
as
Alcohol 
,ether,Iodine, 
volatile oils,Camphor
menthol 
etc 
escape 
from 
the 
formulations
rendering 
them
 
degraded.
 
EXAMPLE:
  
Aromatic
waters  
Elixirs
Some 
types of 
tablets 
which 
contain
aromatic  
water 
(Nitroglycerine
 
tablets)
PREVENTION:
  
Such 
product 
should be placed 
in 
well
closed  
container
Temperature 
should 
be
 
proper.
 
2
) 
LOSS 
OF
 
H20:
 
 
Evaporation 
of 
water 
from 
liquid 
preparations  
will 
cause
concentration 
of the 
drug 
to 
change  with the possibility of
crystilization 
occurring if  the solubility of the drug in the
solvent 
is  
exceeded. 
Water 
loss 
from oil- 
in 
water  
creams
may 
result 
in a decrease in 
volume 
and  
a 
surface 
rubbery
feel. 
Further 
evaporation 
of  
the 
water 
will cause the
emulsion 
to
 
crack.
 
Some 
drugs 
are efflorescent, 
which mean 
they
will lose 
water to 
the 
atmosphere resulting 
in
a 
concentration 
of 
the 
drug 
and 
overall 
weight
loss.
 
Water 
loss 
to 
the 
atmosphere can 
be
prevented 
by 
storing 
the 
pharmaceutical
product 
in a 
well 
closed
 
container.
 
EXAMPL
E
S
 
Saturated 
solution: 
by 
loss 
of 
water 
they become
supersaturated 
and 
precipitate 
as 
crystals 
are
formed
 
.
Emulsions: Loss of 
water 
lead 
to separation 
of 
the
two phases 
and 
change 
to 
other
 
type
Creams: 
especially 
oil/water, 
they become 
dry 
by
loss 
of
 
water
 
3) 
ABSORPTION 
OF 
H20(MOISTURE)
HYGROSCOPITY
 
Hygroscopic 
drugs absorb 
the 
water from 
external
atmosphere 
causing the 
physical
 
degradation.
For 
example, 
some drugs 
are 
delisquent 
(calcium
chloride and 
potassium 
citrate), 
whereas 
others are
hygroscopic 
(glycerol 
and dry 
plant
 
extracts).
Effervescent powders 
and 
tablets 
will 
deteriorate 
if
stored 
in a 
moist
 
atmosphere..
 
EXAMPLE
 
Powders: 
Liquification 
and 
degradation 
may 
occur as  a 
result
of absorption of
 
water
Suppositories 
which 
base 
made 
from 
hydrophilic  
substances
as 
Glycerin, 
Gelatin, 
polyethylene
 
glycol.
The 
consistency 
of these 
forms 
becomes 
jelly-like
appearance.
Products 
should 
be placed in well-closed 
container  
and in
dry
 
place.
 
4)
 
POLYMORPHISM
 
Polymorphs are 
different 
crystal 
forms 
of 
the  
same compound
.Polymorphs 
differs 
from 
one  
another in the 
crystal 
energies,
the 
more  energetic 
ones 
converting 
to 
the 
least  energetic 
or
most 
stable 
one. 
Different  
polymorphs 
of the 
same drug 
may
exhibit  
different 
solubility and melting
 
points.
 
In 
polymorphic 
changes 
crystal 
forms 
are 
changed. A
stable crystal 
form
 
loosens.
This 
may 
cause 
alteration 
in 
solubility 
and 
possibly
crystalline growth 
in aqueous
 
suspensions.
Ex Chloremphenicol
 
Palmitate
Cocoa
 
Butter
 
5)
 
CRYSTAL
 
GROWTH
 
Drugs 
when loose 
water,become 
saturated
and 
crystal 
growth 
occurs.Molecules 
in the
crystal are 
not 
static, 
they 
can grow 
in 
size 
and
move 
when 
there 
is a medium 
to
 
travel.
Crystallization 
is enhanced in 
porous
 
tablets.
 
EXA
M
PLE
 
Carbamazepine 
tablets containing
 
stearic
acid 
form 
column shaped 
crystals 
on
tablet 
surface 
during 
storage 
at 
high
temperatu
re.
 
6)
 
COLOUR 
CHANGES
Colour changes 
are 
of 
two 
types.
Loss of
 colour
 
Development 
of
 
colour
1) Loss of 
colour 
is due
 
to
·
PH
 change
2) 
Development 
of 
colour 
is due
 
to
·
Exposure 
to
 
light
 
EXAMPLE:
Phenolphthalein 
color 
changes as the Ph changes.It
is 
colorless 
in acidic 
solution 
and 
pink 
in
 
basic
.
PREVENTION:
PH 
should 
be
 
adjusted
Exposure 
to 
light should 
be
 
avoided
An 
attempt 
has 
been 
made 
to 
prevent 
the 
fading by
incorporating 
UV 
light 
absorbing
 
material.
 
Physical 
stability
 
(Cont.)
 
Formulation
 
Likely physical
instability
 
problems
 
Ef
f
ects
 
Oral
 
solutions
 
1- 
Loss of
 
flavour
 
2- 
Change 
in
 
taste
 
due 
to interaction
 
with
plastic
 
bottle
4- 
Loss of 
dye
5-
 
Precipitation
6-
 
discoloration
 
Change
 
in
 
smell
 
or
 
3- Presence 
of
 
off
 
flavours
 
feel
 
or
 
taste
 
Physical 
stability
 
(Cont.)
 
Formulation
 
Likely physical
instability
 
problems
 
Ef
f
ects
 
Suspensions
 
1
settling
2
caking
3
crystal
 
growth
 
1-Loss 
of 
drug
content
uniformity in
different 
doses
from the
 
bottle
 
2- 
loss
 
of
elegance.
 
Physical 
stability
 
(Cont.)
 
Formulation
 
Likely physical
instability
 
problems
 
Ef
f
ects
 
Emulsions
 
1
Creaming
2
coalescence
 
1- 
Loss of
drug 
content
uniformity in
different 
doses
from 
the
 
bottle
 
2- 
loss
 
of
elegance
 
Physical 
stability
 
(Cont.)
 
Coalescence
 
Physical 
stability
 
(Cont.)
 
Formulation
 
Likely physical
instability
 
problems
 
Ef
f
ects
 
Tab
l
ets
 
Change
 
in:
a)
Disintegration
 
time
b)
Dissolution
 
profile
c)
Hardness
d)
Appearance 
(soft
 
and
ugly or become  
very
hard)
 
Change 
in
drug
 
release
 
Physical 
stability
 
(Cont.)
 
Formulation
 
Likely physical
instability
 
problems
 
Ef
f
ects
 
Capsules
 
Change
 
in:
a)
Appearance
b)
Dissolution
c)
Strength
 
Change 
in
drug
 
release
 
Physical 
stability
 
(Cont.)
 
Formulation
 
L
i
k
e
ly
 
physi
c
al
 
Ef
f
ects
instability
 
problems
 
Semisolids
(Ointments
and
su
p
po
si
t
o
r
i
es)
 
1. Changes
 
in:
a)
Particle
 
size
b)
Consistency
 
2. Caking
 
or
coalescence
 
3.
 
Bleeding
 
1-Loss 
of
 
drug
content
uniformity
 
2- 
loss
 
of
elegance
 
3-change in
drug
 
release
rate.
 
CHEMICAL
 
DEGRADATION
 
It 
is 
the 
separation 
of chemical
compound 
into 
elements or simpler
compounds. 
Change 
in the 
chemical
nature 
of 
the drug is 
called 
as 
chemical
degradation.
 
TYPES 
OF CHEMICAL
 
DEGRADATION
 
Types 
of chemical 
degradation
 
are
1.
Hydrolysis
2.
Oxidation
3.
Decarboxylation
4.
Isomerization
5.
Polymerization
 
HYDROLYSIS
 
Splitting by
 
water.
Drugs 
with 
functional 
groups 
such 
as 
esters,
amides, 
lactones or lactams 
may 
be susceptible
to 
hydrolytic
 
degradation.
It 
is probably 
the 
most 
commonly 
encountered
mode of 
drug 
degradation 
because of 
the
prevalence 
of such 
groups 
in medicinal 
agents
and the 
ubiquitous nature 
of
 
water.
 
Example
 
ASPIRIN:
Aspirin 
degrade 
into 
salicylic 
acid and
acetic 
acid giving 
vinegar 
like
 
odour.
 
OXIDATION
 
Removal 
of 
an 
electropositive 
atom,
radical 
or 
electron, 
or 
the addition 
of 
an
electronegative 
atom 
or
 
radical.
Types:
Oxidation 
has 
two
 
types
·
Auto-oxidation
·
Photo-oxidation
 
AUTO
-
OXIDATION
 
Oxidation 
in 
which the 
oxygen 
present 
in
the air is
 involved.
This 
process proceeds 
slowly 
under
 
the
influence of atmospheric
 
oxygen
e.g. 
Oil, 
fats 
& 
unsaturated 
compound
can undergo auto-
 
oxidation
 
PHOTO
-
OXIDATION
 
Oxidation 
in 
which 
removal 
of 
the
electron 
is 
involved 
with 
out 
presence 
of
O2.
This type 
is less 
frequently
 
encountered
e.g. 
It 
occurs 
in 
adrenaline, riboflavin 
&
ascorbic 
acid
 etc.
 
DECARBOXYLATION
 
Elimination of 
CO2 
from 
a 
compound.Drug
substances 
having 
a 
carboxylic 
acid 
group are
sometimes susceptible 
to
 decarboxylation,
4-Aminosalicylic 
acid is a 
good
 
example.
 
ISOMERIZATION
 
It is the 
process 
by 
which 
one 
molecule is
transformed 
into 
another molecule which
 
has
exactly 
the 
same 
atoms, 
but 
the 
atoms 
are
rearranged 
e.g. 
A-B-
C 
 
B
-A-C
Conversion 
of 
an 
active 
drug 
into 
a less 
active or
inactive isomer 
having 
same 
structural formula
 
but
different 
stereochemical
 
configuration
 
Types 
of
 
Isomerization:
1)
Optical
 
Isomerization
2)
Geometrical
 
Isomerization
OPTICAL
 
ISOMERIZATION:
A 
change 
in the 
optical 
activity of a 
drug 
may 
result 
as a
change in 
its 
biological
 
activity.
It is 
further divided 
into:
(i)RACEMIZATION
(ii)
 
EPIMERIZATION
 
RACEMIZATION
:
 
It 
involves 
the 
optically active 
form 
of 
a
drug 
into 
its
 enantiomorph.
E.X 
: 
By 
the 
action 
of 
heat 
(-) 
hyoscyamine
is 
readily 
converted 
to 
atropine 
which is
the 
racemic 
mixture of (+) 
& 
(-)
hyoscyamine.
 
Epimerization:
It 
occur 
with the 
compound 
having 
more 
than
one 
asymetric 
carbon 
atom 
in the
 
molecule.
E.X: Under 
prolonged 
storage 
solution
containing 
ergometrine 
is 
decomposed 
by
hydrolysis 
and 
isomerized 
to
 
ergometrinine
.
 
GEOMETRICAL
 
ISOMERIZATION:
 
Loss 
of 
activity 
due 
to 
the 
difference 
in 
potency
exhibited 
by CIS 
& 
TRANS 
isomers 
of some 
organic
compounds.
EX: Active 
form 
of 
VITAMIN 
A 
molecule has 
all 
trans
configuration.In 
aqueous solution as a 
component
of 
multivitamin 
preparation,in 
addition 
to
 
oxidation
VITAMIN 
A 
PALMITATE 
isomerizes 
and 
form 6-mono
cis and 2,6 
di-cis isomers,both 
have 
low
 
potency.
 
PO
L
YM
E
RIZ
A
TION
 
Combination of two or 
more identical 
molecules
to 
form 
a much 
larger 
and 
more 
complex
molecule.
e.g. 
Degradation 
of antiseptic 
formulations 
and
aldehydes 
is 
due
 
to
polymerization.
 
Formaldehyde 
solution 
may
result 
into 
formation 
of 
white 
deposit 
when
 
stand
in
 
cold.
 
PHOTO
 
DEGRADATION
 
Photodegradation
 
is the 
process by 
which 
light-
sensitive 
drugs or 
excipient 
molecules 
are
chemically 
degraded 
by 
light, 
room 
light 
or
sunlight.
PHOTOLYSIS:
It is 
defined 
as 
decomposition of 
a 
drug 
by
 
light.
 
Photodegradation 
of 
Primaquine 
& 
chloroquine 
give
different 
products by 
various
 
pathways.
S
o
diu
m
 
n
i
t
r
o
p
ru
s
i
d
e
 
st
a
b
le
 
f
o
r
 
1
 
y
e
ar
 
i
f
 
p
r
o
t
ec
t
ed
otherwise 
may 
degrade 
after 
4
 
hours.
It 
can 
be 
prevented 
by
 
:
Suitable packing 
in amber 
coloured 
bottles.
Cardboard
 
outers
Aluminium 
foil 
over
 
wraps
.
 
Stabilization 
of 
drugs 
against 
hydrolysis,  
oxidation 
and
photolysis:
TEMPERATURE:
 
All 
the 
drug 
products 
are  
stored 
at  
suitable  
temperatures 
to 
avoid
thermal 
acceleration 
of  
decomposition.
LIGHT:
Light sensitive materials 
are 
stored 
in 
ambered
colour bottles
 
Humidity
Packing materials 
are 
chosen 
(usually 
glass and
plastic) 
to 
prevent 
exposure 
of 
drug 
products 
to
high humid
 
condition.
 
Oxygen
Proper 
packing 
keeping 
the 
oxygen content 
of
the 
solution 
less and 
leaving very little 
head
space 
in the 
bottle above 
the 
drug 
products 
are
methods 
to 
fight 
against
 
oxidation
 
MICROBIAL
 
DEGRADATION
 
Contamination 
of 
a 
product 
may 
sometimes  cause 
a
lot of 
damage 
and 
sometimes 
may 
not  be anything
at 
all. 
Thus 
it is 
dependent on 
the  type 
of 
microbe
and its 
level 
of 
toxicity 
it 
may  
produce.
If 
parenterals 
or 
opthalmic 
formulations are
contaminated, 
it 
may 
cause serious
 
harm.
 
Pyrogens 
which 
are 
the 
metabolic 
products 
of
bacterial 
growth are 
usually 
lipo
polysaccharides 
and 
they 
represent 
a
particularly 
hazardous 
product 
released 
by
gram negative 
bacteria. 
If 
administered
inadvertently 
to 
a 
patient 
they 
may 
cause
chills and
 
fever.
 
PREVENTION 
OF 
MICROBIAL  
DEGRADATION
 
suitably 
designing the
 
containers
 
usually using single dose
 
containers
 
sticking 
to 
proper 
storage
 
conditions
 
adding an 
antimicrobial 
substance
 
as
preservative
.
 
METHOD 
FOR 
DETECTING 
CHEMICAL/  
PHYSICAL
DEGRADATION
 
THERMAL
 
ANALYSIS:
Following 
methods can be used 
for
detection,
 
DIFFERENTIAL SCANNING 
CALORIMETRY 
(DSC)
DIFFERENTIAL THERMAL 
ANALYSIS 
(DTA)
DIFFERENTIAL 
THERMOGRAVIMETRY
 
(DTG)
 
THANK
 
YOU
Slide Note
Embed
Share

Pharmaceutical degradation refers to the process of a formulation in a specific container losing its chemical, microbiological, therapeutic, physical, and toxicological specifications. It can be categorized into physical, chemical, and microbiological degradation. Physical degradation alters the drug's physical nature, such as appearance, organoleptic properties, hardness, and particle size. Factors affecting physical degradation include loss of volatile components, water absorption, crystal growth, polymorphic changes, and color changes. Volatile components like alcohol, ether, and volatile oils can escape from formulations, leading to degradation.

  • Pharmaceutical degradation
  • Physical degradation
  • Chemical degradation
  • Microbiological degradation
  • Factors affecting degradation

Uploaded on Jul 10, 2024 | 3 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. PHARMACEUTICAL DEGRADATION PRESENTED PRESENTED BY: Rama Shukla Deptt. of Pharmaceutics, LNCP,Bhopal BY:

  2. DEGRADATION The condition or process of degrading or being degraded.Decline to a lower quality,condition or level.

  3. PHARMACEUTICAL DEGRADATION The incapacity or incapability of a particular formulation in a specific container to remain within a particular chemical, microbiological, therapeutical, physical & toxicological specification.

  4. ASPIRIN Decompose into acetic acid and salicylicacid giving the acetic acid odour by the break down. The breakdown is a chemical reaction involving the collisions of the molecules.This breakdown is affected by various factors such as presence of oxygen, acidity, alkalinity, moisture and light. This breakdown is what we are calling degradation.

  5. TYPES OF PHARMACEUTICAL DEGRADATION Pharmaceutical degradation is of following type. It can be divided into three major types: 1. Physical degradation 2. Chemical degradation 3. Microbiological degradation

  6. PHYSICAL DEGRADATION It is the degradation which results into the change of physical nature of drug. The formulation is totally changed by way of appearance, organoleptic properties, hardness, brittleness, particle size.

  7. Factors effecting physical degradation are as under: 1. Loss of volatile components 2. Loss of H2O 3. Absorption of H2O 4. Crystal growth 5. Polymorphic changes 6. Colour changes

  8. 1) Loss Of Volatile Components: Many drugs and excipients may be lost from pharmaceutical products at ambient temperature through vaporization. These Volatile components such as Alcohol ,ether,Iodine, volatile oils,Camphor menthol etc escape from the formulations rendering them degraded.

  9. EXAMPLE: Aromatic waters Elixirs Some types of tablets which contain aromatic water (Nitroglycerine tablets) PREVENTION: Such product should be placed in well closed container Temperature should be proper.

  10. 2) LOSS OF H20: Evaporation of water from liquid preparations will cause concentration of the drug to change with the possibility of crystilization occurring if the solubility of the drug in the solvent is exceeded. Water loss from oil- in water creams may result in a decrease in volume and a surface rubbery feel. Further evaporation of the water will cause the emulsion to crack.

  11. Some drugs are efflorescent, which mean they will lose water to the atmosphere resulting in a concentration of the drug and overall weight loss. Water loss to the atmosphere can be prevented by storing the pharmaceutical product in a well closed container.

  12. EXAMPLES Saturated solution: by loss of water they become supersaturated and precipitate as crystals are formed . Emulsions: Loss of water lead to separation of the two phases and change to other type Creams: especially oil/water, they become dry by loss of water

  13. 3) ABSORPTION OF H20(MOISTURE) HYGROSCOPITY Hygroscopic drugs absorb the water from external atmosphere causing the physical degradation. For example, some drugs are delisquent (calcium chloride and potassium citrate), whereas others are hygroscopic (glycerol and dry plant extracts). Effervescent powders and tablets will deteriorate if stored in a moist atmosphere..

  14. EXAMPLE Powders: Liquification and degradation may occur as a result of absorption of water Suppositories which base made from hydrophilic substances as Glycerin, Gelatin, polyethylene glycol. The consistency of these forms becomes jelly-like appearance. Products should be placed in well-closed container and in dry place.

  15. 4) POLYMORPHISM Polymorphs are different crystal forms of the same compound .Polymorphs differs from one another in the crystal energies, the more energetic ones converting to the least energetic or most stable one. Different polymorphs of the same drug may exhibit different solubility and melting points.

  16. In polymorphic changes crystal forms are changed. A stable crystal form loosens. This may cause alteration in solubility and possibly crystalline growth in aqueous suspensions. Ex Chloremphenicol Palmitate Cocoa Butter

  17. 5) CRYSTALGROWTH Drugs when loose water,become saturated and crystal growth occurs.Molecules in the crystal are not static, they can grow in size and move when there is a medium to travel. Crystallization is enhanced in porous tablets.

  18. EXAMPLE Carbamazepine tablets containingstearic acid form column shaped crystals on tablet surface during storage at high temperature.

  19. 6) COLOUR CHANGES Colour changes are of two types. Loss of colour Development of colour 1) Loss of colour is due to PH change 2) Development of colour is due to Exposure to light

  20. EXAMPLE: Phenolphthalein color changes as the Ph changes.It is colorless in acidic solution and pink in basic. PREVENTION: PH should be adjusted Exposure to light should be avoided An attempt has been made to prevent the fading by incorporating UV light absorbing material.

  21. Physical stability (Cont.) Formulation Likely physical instability problems Effects Oral solutions 1- Loss of flavour 2- Change in taste 3- Presence of off flavoursfeel or Change in smell or taste due to interaction with plastic bottle 4- Loss of dye 5- Precipitation 6- discoloration

  22. Physical stability (Cont.) Formulation Likely physical instability problems Effects Suspensions 1 settling 2 caking 3 crystal growth 1-Loss of drug content uniformity in different doses from the bottle 2- loss of elegance.

  23. Physical stability (Cont.) Formulation Likely physical instability problems Effects 1 Creaming 2 coalescence Emulsions 1- Loss of drug content uniformity in different doses from the bottle 2- loss of elegance

  24. Physical stability (Cont.) Coalescence

  25. Physical stability (Cont.) Formulation Likely physical instability problems Change in: a) Disintegration time b) Dissolution profile c) Hardness d) Appearance (soft and ugly or become very hard) Effects Tablets Change in drug release

  26. Physical stability (Cont.) Formulation Likely physical instability problems Change in: a) Appearance b) Dissolution c) Strength Effects Capsules Change in drug release

  27. Physical stability (Cont.) Formulation Likely physical instability problems Effects Semisolids (Ointments and suppositories) 1. Changes in: a) Particle size b) Consistency 1-Loss of drug content uniformity 2- loss of elegance 2. Caking or coalescence 3-change in drug release rate. 3. Bleeding

  28. CHEMICAL DEGRADATION It is the separation of chemical compound into elements or simpler compounds. Change in the chemical nature of the drug is called as chemical degradation.

  29. TYPES OF CHEMICAL DEGRADATION Types of chemical degradation are 1. Hydrolysis 2. Oxidation 3. Decarboxylation 4. Isomerization 5. Polymerization

  30. HYDROLYSIS Splitting by water. Drugs with functional groups such as esters, amides, lactones or lactams may be susceptible to hydrolytic degradation. It is probably the most commonly encountered mode of drug degradation because of the prevalence of such groups in medicinal agents and the ubiquitous nature of water.

  31. Example ASPIRIN: Aspirin degrade into salicylic acid and acetic acid giving vinegar like odour.

  32. OXIDATION Removal of an electropositive atom, radical or electron, or the addition of an electronegative atom or radical. Types: Oxidation has two types Auto-oxidation Photo-oxidation

  33. AUTO-OXIDATION Oxidation in which the oxygen present in the air is involved. This process proceeds slowly underthe influence of atmospheric oxygen e.g. Oil, fats & unsaturated compound can undergo auto- oxidation

  34. PHOTO-OXIDATION Oxidation in which removal of the electron is involved with out presence of O2. This type is less frequently encountered e.g. It occurs in adrenaline, riboflavin & ascorbic acid etc.

  35. DECARBOXYLATION Elimination of CO2 from a compound.Drug substances having a carboxylic acid group are sometimes susceptible to decarboxylation, 4-Aminosalicylic acid is a good example.

  36. ISOMERIZATION It is the process by which one molecule is transformed into another molecule whichhas exactly the same atoms, but the atoms are rearranged e.g. A-B-C B-A-C Conversion of an active drug into a less active or inactive isomer having same structural formulabut different stereochemicalconfiguration

  37. Types of Isomerization: 1) Optical Isomerization 2) Geometrical Isomerization OPTICAL ISOMERIZATION: A change in the optical activity of a drug may result as a change in its biological activity. It is further divided into: (i)RACEMIZATION (ii) EPIMERIZATION

  38. RACEMIZATION: It involves the optically active form of a drug into its enantiomorph. E.X : By the action of heat (-) hyoscyamine is readily converted to atropine which is the racemic mixture of (+) & (-) hyoscyamine.

  39. Epimerization: It occur with the compound having more than one asymetric carbon atom in the molecule. E.X: Under prolonged storage solution containing ergometrine is decomposed by hydrolysis and isomerized to ergometrinine.

  40. GEOMETRICAL ISOMERIZATION: Loss of activity due to the difference in potency exhibited by CIS & TRANS isomers of some organic compounds. EX: Active form of VITAMIN A molecule has all trans configuration.In aqueous solution as a component of multivitamin preparation,in addition tooxidation VITAMIN A PALMITATE isomerizes and form 6-mono cis and 2,6 di-cis isomers,both have lowpotency.

  41. POLYMERIZATION Combination of two or more identical molecules to form a much larger and more complex molecule. e.g. Degradation of antiseptic formulations and aldehydes is due to polymerization. Formaldehyde solution may result into formation of white deposit when stand in cold.

  42. PHOTODEGRADATION Photodegradation is the process by which light- sensitive drugs or excipient molecules are chemically degraded by light, room light or sunlight. PHOTOLYSIS: It is defined as decomposition of a drug by light.

  43. Photodegradation of Primaquine & chloroquine give different products by various pathways. Sodium nitropruside stable for 1 year if protected otherwise may degrade after 4 hours. It can be prevented by : Suitable packing in amber coloured bottles. Cardboard outers Aluminium foil over wraps.

  44. Stabilization of drugs against hydrolysis, oxidation and photolysis: TEMPERATURE: All the drug products are stored at suitable temperatures to avoid thermal acceleration of decomposition. LIGHT: Light sensitive materials are stored in ambered colour bottles

  45. Humidity Packing materials are chosen (usually glass and plastic) to prevent exposure of drug products to high humid condition. Oxygen Proper packing keeping the oxygen content of the solution less and leaving very little head space in the bottle above the drug products are methods to fight against oxidation

  46. MICROBIAL DEGRADATION Contamination of a product may sometimes cause a lot of damage and sometimes may not be anything at all. Thus it is dependent on the type of microbe and its level of toxicity it may produce. If parenterals or opthalmic formulations are contaminated, it may cause serious harm.

  47. Pyrogens which are the metabolic products of bacterial growth are usually lipo polysaccharides and they represent a particularly hazardous product released by gram negative bacteria. If administered inadvertently to a patient they may cause chills and fever.

  48. PREVENTION OF MICROBIAL DEGRADATION suitably designing thecontainers usually using single dosecontainers sticking to proper storageconditions adding an antimicrobial substanceas preservative.

  49. METHOD FOR DETECTING CHEMICAL/ PHYSICAL DEGRADATION THERMAL ANALYSIS: Following methods can be used for detection, DIFFERENTIAL SCANNING CALORIMETRY (DSC) DIFFERENTIAL THERMAL ANALYSIS (DTA) DIFFERENTIAL THERMOGRAVIMETRY (DTG)

  50. THANK YOU

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#